73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
A new strategy to enhance gene therapy for sickle cell disease

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi
Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

by Queen Mary, University of LondonInhibition of FGFR1 limits invasion in pre-clinical models of PDAC.ARepresentative H&E images of MIA PaCa-2: PS1 organotypics treated with 100 n

Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

by Queen Mary, University of LondonInhibition of FGFR1 limits invasion in pre-clinical models of PDAC.ARepresentative H&E images of MIA PaCa-2: PS1 organotypics treated with 100 n
'Magic bullet' takes aim at pancreatic cancer

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they
Interdisciplinary research team uses AI to quickly discover personalized cancer cures

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre
Do pancreatic cysts become cancerous?

Do pancreatic cysts become cancerous?

by Christos Fountzilas, Md,Roswell Park Cancer InstituteCredit: Roswell Park Cancer InstituteWhat is a pancreatic cyst?Pancreatic cysts are water or mucus filled structures in the pancreas, simi

Do pancreatic cysts become cancerous?

by Christos Fountzilas, Md,Roswell Park Cancer InstituteCredit: Roswell Park Cancer InstituteWhat is a pancreatic cyst?Pancreatic cysts are water or mucus filled structures in the pancreas, simi
A new combination therapy regimen shows promising results for prostate cancer

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress
Living alone doesn't have to mean being lonely, says study

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un
Video educates and connects men to prostate cancer screening options

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me
Researchers pinpoint tumor-related protein, slow progression of cancers

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.
Research perspective: Cancer prevention with rapamycin

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t